Search Within

Samuel Aaron Funt

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (24)
  2. Journal Article (17)
  3. Editorial (1)
Groups
  1. Department of Medicine (42)
  2. Genitourinary Oncology Service (42)
  3. Human Oncology and Pathogenesis Program (42)
  4. Solid Tumor Oncology Division (42)
  5. Weinberg Fellows (42)
  6. Department of Pathology and Laboratory Medicine (41)

More Groups

People
  1. David Solit (40)
  2. Dean Bajorin (38)
  3. Gopakumar Iyer (35)
  4. Hikmat Al-Ahmadie (35)
  5. Jonathan Rosenberg (34)
  6. Min Yuen Teo (28)

More People

Years
  1. 2024 (5)
  2. 2023 (3)
  3. 2022 (7)
  4. 2021 (5)
  5. 2020 (9)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (23)
  2. Clinical Cancer Research (3)
  3. JCO Precision Oncology (3)
  4. European Urology (2)
  5. American Journal of Surgical Pathology (1)
  6. Bladder Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (26)
  2. American Association for Cancer Research (4)
  3. Elsevier Science, Inc. (3)
  4. Nature Publishing Group (3)
  5. American Society for Clinical Investigation (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Invasive urothelial cancer (iUC) with FGFR3 hotspot mutation/fusion (FGFR3+): A molecularly and clinically distinctive entity?
    Meeting Abstract

    Mota, J. M. S. C.; Teo, M. Y.; Li, H.; Balar, A. V.; Milowsky, M. I.; Funt, S. A.; Lee, C. H.; Regazzi, A. M.; Berger, M. F.; Solit, D. B.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT)
    Meeting Abstract

    Dean, L. W.; Wong, N. C.; Dason, S.; Isharwal, S.; Donoghue, M.; Jia, L.; Tap, W. D.; Joseph, G.; Funt, S. A.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Characterization of actionable genetic alterations to guide targeted therapy for metastatic urothelial carcinoma
    Meeting Abstract

    Almassi, N.; Pietzak, E. J.; Funt, S. A.; Schultz, N.; Dalbagni, G.; Bochner, B. H.; Al-Ahmadie, H.; Bajorin, D. F.; Rosenberg, J. E.; Iyer, G.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • PD-L1 expression in urothelial carcinoma with predominant or pure variant histology: Concordance among 3 commonly used and commercially available antibodies
    Journal Article

    Reis, H.; Serrette, R.; Posada, J.; Lu, V.; Chen, Y. B.; Gopalan, A.; Fine, S. W.; Tickoo, S. K.; Sirintrapun, S. J.; Iyer, G.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • DNA damage repair (DDR) germline mutations in patients (Pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Carlo, M. I.; Vijai, J.; Mandelker, D.; Kemel, Y.; Regazzi, A. M.; Zhang, L.; Stadler, Z. K.; Walsh, M. F.; Cadoo, K. A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next generation sequencing of urothelial bladder cancer: Memorial Sloan Kettering Cancer Center experience in 454 patients
    Meeting Abstract

    Isharwal, S.; Audenet, F.; Drill, E. N.; Ostrovnaya, I.; Pietzak, E. J.; Al-Ahmadie, H.; Cha, E. K.; Donahue, T. F.; Teo, M. Y.; Funt, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression in urothelial carcinoma with divergent differentiation, concordance among three antibodies
    Meeting Abstract

    Reis, H.; Serrette, R. N.; Gopalan, A.; Chen, Y. B.; Fine, S. W.; Tickoo, S.; Sirintrapun, S. J.; Iyer, G.; Funt, S. A.; Teo, M. Y.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Comparison of somatic mutation profiles from cell free DNA (cfDNA) versus tissue in metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Cheng, M. L.; Shady, M.; Cipolla, C. K.; Funt, S.; Arcila, M. E.; Al-Ahmadie, H.; Rosenberg, J. E.; Bajorin, D. F.; Berger, M. F.; Tsui, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save